1.0EFA - Annual Reporthttps://efanet.org/annual-reportrich600338<blockquote class="wp-embedded-content" data-secret="vWhJ5sD2xi"><a href="https://efanet.org/annual-report/2021/inform/">Inform</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://efanet.org/annual-report/2021/inform/embed/#?secret=vWhJ5sD2xi" width="600" height="338" title="“Inform” — EFA - Annual Report" data-secret="vWhJ5sD2xi" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://efanet.org/annual-report/wp-includes/js/wp-embed.min.js </script> EFA generates evidence, shares knowledge about, campaigns and raises awareness of allergy and airway diseases. We bring to attention EFA’s influence and activities through our various platforms that reach out to patients, healthcare professionals and policymakers. In 2021, we launched two new projects generating patient evidence, the European Atopic Eczema Consensus Europe project, and DIG_IT, […]